Human PLCG2 haploinsufficiency results in a novel natural killer cell immunodeficiency
Journal of Allergy and Clinical Immunology · 2024-01 · 153 (1) · 216-229
DOI: 10.1016/j.jaci.2023.09.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2024-01. Verfasst von Joshua B Alinger und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Pediatrics, St Louis Children's Hospital, Washington University School of Medicine, St Louis, Mo. Hauptthemen laut MEDLINE: Haploinsufficiency, Immunologic Deficiency Syndromes, Phospholipase C gamma. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIAMS NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Although most individuals effectively control herpesvirus infections, some suffer from severe and/or recurrent infections. A subset of these patients possess defects in natural killer (NK) cells, lymphocytes that recognize and lyse herpesvirus-infected cells; however, the genetic etiology is rarely diagnosed. PLCG2 encodes a signaling protein in NK-cell and B-cell signaling. Dominant-negative or gain-of-function variants in PLCG2 cause cold urticaria, antibody deficiency, and autoinflammation. However, loss-of-function variants and haploinsufficiency have not been reported to date. OBJECTIVES: The investigators aimed to identify the genetic cause of NK-cell immunodeficiency in 2 families and herein describe the functional consequences of 2 novel loss-of-function variants in PLCG2. METHODS: The investigators employed whole-exome sequencing in conjunction with mass cytometry, microscopy, functional assays, and a mouse model of PLCG2 haploinsufficiency to investigate 2 families with NK-cell immunodeficiency. RESULTS: The investigators identified novel heterozygous variants in PLCG2 in 2 families with severe and/or recurrent herpesvirus infections. In vitro studies demonstrated that these variants were loss of function due to haploinsufficiency with impaired NK-cell calcium flux and cytotoxicity. In contrast to previous PLCG2 variants, B-cell function remained intact. Plcg2+/- mice also displayed impaired NK-cell function with preserved B-cell function, phenocopying human disease. CONCLUSIONS: PLCG2 haploinsufficiency represents a distinct syndrome from previous variants characterized by NK-cell immunodeficiency with herpesvirus susceptibility, expanding the spectrum of PLCG2-related disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Rheumatology, Department of Pediatrics, St Louis Children's Hospital, Washington University School of Medicine, St Louis, Mo.
- Departments of Pediatrics, Baylor College of Medicine, Center for Human Immunobiology, Texas Children's Hospital, Houston, Tex; Center for Human Immunobiology, Texas Children's Hospital, Houston, Tex; Department of Pedi…
- Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St Louis, Mo.
- Departments of Pediatrics, Baylor College of Medicine, Center for Human Immunobiology, Texas Children's Hospital, Houston, Tex; Center for Human Immunobiology, Texas Children's Hospital, Houston, Tex.
- Departments of Molecular and Human Genetics, Baylor College of Medicine, Texas Children's Hospital, Houston, Tex.
- Hamad Medical Center, Doha, Qatar.
Förderung
- NIAID NIH HHS
- NIAMS NIH HHS
- NIGMS NIH HHS
- NCI NIH HHS
- NCATS NIH HHS
- NHGRI NIH HHS
Zitieren
APA
Alinger, J. B., Mace, E. M., Porter, J. R., Mah-Som, A. Y., Daugherty, A. L., Li, S., Throm, A. A., Pingel, J. T., Saucier, N., Yao, A., Chinn, I. K., Lupski, J. R., Ehlayel, M., Keller, M., Bowman, G. R., Cooper, M. A., Orange, J. S., & French, A. R. (2024). Human PLCG2 haploinsufficiency results in a novel natural killer cell immunodeficiency. Journal of Allergy and Clinical Immunology, 153(1), 216-229. https://doi.org/10.1016/j.jaci.2023.09.002
Vancouver
Alinger JB, Mace EM, Porter JR, Mah-Som AY, Daugherty AL, Li S, et al. Human PLCG2 haploinsufficiency results in a novel natural killer cell immunodeficiency. Journal of Allergy and Clinical Immunology. 2024;153(1):216-229. doi:10.1016/j.jaci.2023.09.002
BibTeX
@article{Alinger2024,
author = {Alinger, Joshua B and Mace, Emily M and Porter, Justin R and Mah-Som, Annelise Y and Daugherty, Allyssa L and Li, Stephanie and Throm, Allison A and Pingel, Jeanette T and Saucier, Nermina and Yao, Albert and Chinn, Ivan K and Lupski, James R and Ehlayel, Mohammad and Keller, Michael and Bowman, Greg R and Cooper, Megan A and Orange, Jordan S and French, Anthony R},
title = {Human PLCG2 haploinsufficiency results in a novel natural killer cell immunodeficiency},
journal = {Journal of Allergy and Clinical Immunology},
year = {2024},
volume = {153},
number = {1},
pages = {216--229},
doi = {10.1016/j.jaci.2023.09.002}
}
EUVIMED